Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

August 18, 2019

Primary Completion Date

May 14, 2022

Study Completion Date

July 30, 2022

Conditions
MalariaVivax MalariaFalciparum Malaria
Interventions
DRUG

primaquine

Primaquine regimen over 7 days (1.0 mg/kg/day for 7 days)

Trial Locations (3)

Unknown

Icddrb, Upazila

Arba Minch University, Arba Minch

Puskesmas Mangili, Dusun Tenggara

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

collaborator

Tribhuvan University, Nepal

OTHER

collaborator

Arba Minch University

OTHER

collaborator

Addis Ababa University

OTHER

lead

Menzies School of Health Research

OTHER

NCT03916003 - Reducing the Risk of P. Vivax After Falciparum Infections in Co-endemic Areas | Biotech Hunter | Biotech Hunter